World-First Pilot Study Explores New Cholangiocarcinoma Treatment By Steve|2024-12-13T18:18:15+13:00December 13th, 2024|Categories: All, Clinical Trials|Tags: AGITG, durvalumab, PARP. Olaparib| Read More 0
Meet GEM/CIS/DURVA: A Formidable Trio in the Fight Against Cancer By Steve|2024-10-13T19:18:59+13:00July 18th, 2024|Categories: All, Treatments, Trials & Studies, Z-Legacy|Tags: durvalumab, Gem/Cis/Durva| Read More 0
Merck’s Keytruda: A New Hope in Biliary Tract Cancer By Steve|2024-10-11T16:07:51+13:00November 5th, 2023|Categories: All, Z-Legacy|Tags: durvalumab, Infinzi, Keytruda| Read More 0
PBAC Recommends IMFINZI (durvalumab) for Cholangiocarcinoma Patients in Australia By Steve|2024-10-11T16:07:53+13:00August 29th, 2023|Categories: All, Media, Updates, Z-Legacy|Tags: durvalumab| Read More 0
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer By Steve|2024-10-11T16:08:05+13:00December 2nd, 2022|Categories: Publication, Z-Legacy|Tags: Clinical Trial, durvalumab, Topaz| Read More 0